![Philipp Mathieu](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Philipp Mathieu was President & Chief Executive Officer at Immunovia AB from 2022 to 2023.
Mr. Mathieu completed graduate studies at Bayes Business School.
| Sociétés | Poste | Fin |
|---|---|---|
| IMMUNOVIA AB | Directeur Général | 30/04/2023 |
Actives
Inactives
Sociétés cotées
Entreprise privées
| Entreprise privées | 2 |
|---|---|
Bayes Business School
 Bayes Business School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Immunovia AB
 Immunovia AB Pharmaceuticals: MajorHealth Technology Provides blood-based test for diagnosis of pancreatic cancer | Health Technology |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national
